In Vivo Real-time Detection of Circulating Melanoma Cells
University of Arkansas · NCT01776905
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 75
- US sites recruiting
- 1
- Study start
- February 2013
- Record last updated
- June 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.
Conditions: Melanoma
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 to 80 years
- Histological documented diagnosis of melanoma
- Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
- Must be able to sit still for 90 minutes
Exclusion Criteria
- Active infection
- Current and significant medical or surgical condition as determined by the Investigator
- Diagnosis or evidence of organic brain syndrome
- Pregnancy or breastfeeding
Recruiting US locations
University of Arkansas for Medical Sciences
Little Rock, AR 72205
Site contact: Jumin Sunde, MD · 501-603-1214 · JSunde2@uams.edu
Study contacts (from the official record)
- Jumin Sunde, MD · 501-526-6990 · Jsunde2@uams.edu
- Daniel Dunham · 5016868274 · ddunham@uams.edu
Similar studies in Arkansas
All healthy volunteers studies in Arkansas →- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Little Rock, AR + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- North Little Rock, AR + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Sitryx Therapeutics Ltd
- Location
- Arkansas City, AR + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
Mead Johnson Nutrition
- Location
- Jonesboro, AR + 9 other US sites
- Eligibility basics
- Ages 0 mo–0 mo